adMare BioInnovations
About adMare
With a wealth of scientific discovery, Canada is primed to be a global leader in life sciences. To realize this potential, adMare uses its scientific and commercial expertise, specialized R&D infrastructure, and investment capital to build investable companies, robust ecosystems and industry-ready talent – and re-invests its returns back into the Canadian industry to ensure it is sustained for the long-term.
À propos d’adMare
Grâce à la richesse de ses découvertes scientifiques, le Canada est prêt à devenir un leader mondial dans le domaine des sciences de la vie. Pour réaliser ce potentiel, adMare utilise son expertise scientifique et commerciale, son infrastructure de R&D spécialisée et son capital d’investissement pour développer des entreprises susceptibles de recevoir des investissements, des écosystèmes robustes et des talents prêts à travailler dans l’industrie - et réinvestit ses bénéfices dans l’industrie canadienne pour assurer son maintien à long terme.
Accelerators & Incubators , Biotechnology, Investors, Not-for-profit, Therapeutics
- Antibodies
- Antigen
- Autoimmune Diseases
- Cardiovascular Disease
- Cellular Medicine
- Drug Delivery
- Drug Discovery
- Gene Therapy
- Genomics
- Immune Therapy
- Inflammatory Diseases
- Metabolic Diseases
- Microbiome
- mRNA
- Nanomedicine
- Neurological Diseases
- Oncology
- Ophthalmology
- Pediatrics
- Radio Pharmaceuticals
- Regenerative Medicine
- Regulatory
- Teaching and Training
- Therapeutics
Facilities & Real Estate , Financial & Insurance Services , Lab Services , Strategic Consulting
adMare BioInnovations is a pan-Canadian enterprise that partners with Canadian researchers and SMEs to develop innovative therapeutic products. Our focus is on expanding the Canadian life sciences ecosystem by creating new companies of scale, providing specialized expertise and infrastructure to help existing life sciences companies scale up, and driving the growth of those companies into Canadian anchors by training the next generation of highly qualified personnel. Our partnered programs and companies can be supported by direct investment and our internal in-kind resources, which cover the main stages of drug discovery and preclinical drug development, in particular: • Target Validation and deconvolution: Gene expression profiling, genotyping, antigen generation, off-target testing • Assay development: Functional, biochemical, cell-based, biophysical assays • Medicinal chemistry: Expertise in small molecule and peptide drug discovery and Antibody-Drug conjugation (ADC) chemistry. Rational drug design, SAR exploration and lead optimization. Route scouting and scale up capabilities to enable technology transfer • Pharmacology/toxicology: In vitro ADME / toxicology, safety, in vivo pharmacokinetics / pharmacodynamics • Pharmaceutical preparation: Formulation, solubility, stability, analytical / bioanalytical method development and validation (including human), COG analysis, API release specifications, scale-up and transfer • Biologic development: Antibody generation, characterization, production / optimization, humanization, affinity maturation, manufacturing and cell-line production, regulatory manufacturing, clinical plans and risk and safety assessment • Strategic business development, legal and IP support
Pre-Seed, Seed
We are working On:
We are actively developing novel therapeutic programs in areas of high unmet need. Our partnered programs will launch with the creation of new Canadian anchor companies with strong potential for external investment or contribute to the scale-up of existing existing Canadian SMEs.
We are looking For:
We are seeking academics and Canadian SMEs seeking to partner on innovative, preclinical drug development programs for novel small molecules, biologics and platform technologies.
Member Profile
Accelerators & Incubators , Biotechnology, Investors, Not-for-profit, Therapeutics
adMare BioInnovations
Platinum Sponsor
- Website www.admarebio.com
- Phone +1 (604) 827 1147
- Email info@admarebio.com
- Address
2405 Wesbrook Mall, 4th Floor
Vancouver, BC
V6T 1Z3 - Leadership Contact
Mounia Azzi, Vice President, Program Development & Partnerships
November 28, 2024
adMare BioInnovations Spins Out Analytical Services to Paraza Pharma, Catalyzing Growth and Innovation
October 22, 2024
adMare BioInnovations Celebrates Successes of adMare Tx Accelerator Companies, Concludes Ontario Partnership with MaRS
September 20, 2024
adMare BioInnovations Appoints Marc Rivière to its Board of Directors
No current content.